Articles tagged as "Issue #73 - 24 September 2009"

HIV This Week Issue #73

Welcome to the 73rd issue of HIV This Week! In this issue, we try out elements of a new format and cover these topics: civil society responses (how civil society activism contributed to HIV treatment access in Thailand), vaccines (exciting news about two new broad and potent neutralizing antibodies), injecting drug use (where can you get opioid substitution treatment in prisons?), household resilience (what life course analysis tells us about how to alleviate HIV stressors for households and individuals?), HIV, TB, and national responses (how did things get this bad in South Africa and what to do about it now urgently?), men who have sex with men (how to start to respond in sub-Saharan Africa?) microbicides (Griffithsin: an HIV entry inhibitor candidate with a lot of promise; what do you know about disruption of tight junctions and microbicide safety?), PMTCT health care delivery (health workers in Hanoi, Viet Nam speak out on their problems providing good services; procurement flows and supportive supervision need improvement in Cameroon to meet its 2010 objective of 50% of pregnant women offered HIV testing), gender (widows, widowers, and heterosexual HIV transmission in Manicaland, Zimbabwe), paediatric comorbidity (When will there be a measles outbreak in Lusaka, Zambia?), epidemiology (population attributable fractions in a national sex work study in Togo; how does refusal to participate in a national household survey affect HIV estimates in high HIV testing settings?), and global, multilateral, bilateral responses (lessons from Brazil on how to shape global policy).

To find out how you can access a majority of scientific journals free of charge, please see the last page of this issue or check the HIV This Week website clicking here.

If you are reading this through the kindness of a friend and would like to subscribe to receive HIV This Week pdf issues by email, you can sign up by clicking here. To unsubscribe, please click the following link: unsubscribe.

W e want to be as helpful to you as we can, so please let us know what your interests are and what you think of HIV This Week by sending a comment to hivthisweek@unaids.org or by posting one on the HIV This Week weblog. If you would like to recommend an article for inclusion, please contact HIV This Week here. .

Don’t forget that you can find a wealth of information on the HIV epidemic and responses to it at www.unaids.org .

 

Cate Hankins Brian Houle Tania Lemay Precious Lunga
Chief Scientific Adviser Intern Research Consultant Research Officer

Your rating: None Average: 5 (1 vote)
  • Share this!
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Civil society responses

Challenge and co-operation: civil society activism for access to HIV treatment in Thailand.Ford N, Wilson D, Cawthorne P, Kumphitak A, Kasi-Sedapan S, Kaetkaew S, Teemanka S, Donmon B, Preuanbuapan C. Trop Med Int Health. 2009; 14: 258-66 .

 

Civil society has been a driving force behind efforts to increase access to treatment in Thailand. A focus on HIV medicines brought civil society and non-governmental and government actors together to fight for a single cause, creating a platform for joint action on practical issues to improve care for people with HIV within the public health system. The Thai Network of People with HIV/AIDS, in partnership with other actors, has provided concrete support for patients and for the health system as a whole; its efforts have contributed significantly to the availability of affordable generic medicines, early treatment for opportunistic infections, and an informed and responsible approach towards antiretroviral treatment that is critical to good adherence and treatment success. This change in perception of people living with HIV from ‘passive receiver’ to ‘co-provider’ of health care has led to improved acceptance and support within the healthcare system. Today, most people living with HIV in Thailand can access treatment, and efforts have shifted to supporting care for excluded populations.

 

For full text access click here: 1, 2.

Editors’ note: This ‘participant-observers’ perspective, written by representatives of AIDS ACCESS Foundation, the Thai Network of People living with HIV (TNP+) and Médecins Sans Frontières, describes how civil society activism in Thailand pushed the government to increase availability of affordable antiretroviral drugs and then provided practical support to implementation of treatment programmes. Civil society groups played a pivotal role in Thailand’s decision to establish universal health care coverage for its citizens and used legal and other strategies to fight intellectual property restrictions to medicines, including non-HIV medicines. The groups represented by the co-authors developed a strategy for central involvement of trained people living with HIV in the scale up of treatment programmes through providing systematic peer support in ‘Comprehensive and Continuous Care Centres’ in hospitals. This rich historical analysis of policy change in Thailand is well worth the read.

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Vaccines

Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target. Walker LM, Phoga SK, Chan-Hui P-Y, Wagner D, Phung P, Goss JL, Wrin T, Simek MD, Fling S, Mitcham JL, Lehrman JK, Priddy FH, Olsen OA, Frey SM, Hammond PW, Protocol G Principal Investigators, Kaminsky S, Zamb T, Moyle M, Koff WC, Poignard P, Burton DL. Science. Published online September 3, 2009. Science DOI: 10.1126/science.1178746

Broadly neutralizing antibodies, which develop over time in some HIV-1-infected individuals, define critical epitopes for HIV vaccine design. Using a systematic approach, Walker and colleagues examined neutralization breadth in the sera of about 1800 HIV-1-infected individuals, primarily infected with non-clade B viruses, and selected donors for monoclonal antibody generation. They used a high-throughput neutralization screen of antibody-containing culture supernatants from approximately 30,000 activated memory B cells from a clade A-infected African donor to isolate two potent monoclonal antibodies that target a broadly neutralizing epitope. This epitope is preferentially expressed on trimeric Envelope protein and spans conserved regions of variable loops of the gp120 subunit. The results provide a framework for the design of new vaccine candidates for the elicitation of broadly neutralizing antibody responses.

For full text access click here: 1

Editors’ note: The two novel broadly neutralising antibodies described here are the first to be discovered in more than a decade and the first to be isolated from a donor in sub-Saharan Africa. They not only target multiple strains of HIV, i.e. they are broadly neutralising, but they are very potent, binding tightly to the virus and working at minute levels compared to previously discovered neutralising antibodies. As well, they reveal a new vulnerable easier-to-reach spot on the virus that no previously known antibody targets. The unusual features of these two monoclonal antibodies provide exciting new leads for the design of HIV vaccines that would stimulate the body to make potent antibodies that would be active against a broad range of strains of the virus when a person is exposed to the virus.

Your rating: None Average: 1 (1 vote)
  • Share this!
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Injecting drug use

A Literature Review of International Implementation of Opioid Substitution Treatment in Prisons: Equivalence of Care? Larney S, Dolan K. Eur Addict Res. 2009; 15: 107-12.

Opioid substitution treatment is an effective treatment for heroin dependence. The World Health Organization has recommended that opioid substitution treatment be implemented in prisons because of its role in reducing drug injection and associated problems such as HIV transmission. The aim of this paper was to examine the extent to which opioid substitution treatment has been implemented in prisons internationally. As of January 2008, opioid substitution treatment had been implemented in prisons in at least 29 countries or territories. For 20 of those countries, the proportion of all prisoners in opioid substitution treatment could be calculated, with results ranging from less than 1% to over 14%. At least 37 countries offer opioid substitution treatment in community settings, but not prisons. This study has identified an increase in the international implementation of opioid substitution treatment in prisons. However, there remain large numbers of prisoners who are unable to access opioid substitution treatment, even in countries that provide such programs. This raises issues of equivalence of care for prisoners and HIV prevention in prisons.

For full text access click here: 1

Editors’ note: Opioid substitution therapy, the most cost-effective treatment available for heroin dependence, is available in 66 countries and territories, including low- and middle-income countries such as China, Indonesia, and Iran. The largest prison programmes are in Ireland, Scotland, and Spain with 12 to 14% of inmates in these countries receiving opioid substitution treatment. Some countries unnecessarily restrict access to inmates serving sentences of a particular length, to those who were in treatment before incarceration, or to those who can confirm that they have a post-release treatment place. Furthermore, the 37 countries which offer opioid substitution therapy in the community but not in prisons are contravening the multiple international covenants and legal instruments that entitle incarcerated people access to health services equivalent to those available in the general community in their countries. Thus, despite prison access to opioid substitution treatment having increased from 5 countries in 1996 to 29 in 2008, much remains to be done to improve coverage worldwide both in prisons and in the community.

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Household resilience

Household impacts of AIDS: using a life course analysis to identify effective, poverty-reducing interventions for prevention, tratment, and care. Loewenson R, Whiteside A, Hadingham J. Aids Care. 2009; 21:1032-1041

 

A life course approach was used to assess household level impacts and inform interventions around HIV risk and AIDS vulnerability across seven major age-related stages of life. The focus was sub-Saharan Africa. The authors provided a qualitative review of evidence from published literature, particularly multicountry reviews on impacts of AIDS, on determinants of risk and vulnerability, and reports of large surveys. Areas of potential stress from birth to old age in households affected by AIDS, and interventions for dealing with these specific stresses were identified. While specific interventions for HIV are important at different stages, achieving survival and development outcomes demands a wider set of health, social security, and development interventions. One way to determine the priorities amongst these actions is to give weighting to interventions that address factors that have latent impacts later in life, which interrupt accumulating risk, or that change pathways to reduce the risk of both immediate and later stress. This qualitative review suggests that interventions, important for life cycle transitions in generalized epidemics where HIV risk and AIDS vulnerability are high, lie within and outside the health sector, and suggests examples of such interventions.

Editors’ note: A life course concept views people as passing though various transitions and stages in life with events at one stage having effects at later stages. Points of stress in the life cycle that HIV can affect offer opportunities to influence pathways of accumulating vulnerability. These can range from the obvious example of preventing mother-to-child transmission by antiretroviral prophylaxis to broader interventions, such as promoting more open communication within families. HIV influences the number and quality of ‘buffers’ available to deal with stress, including the buffers of social support, financial resources, and good health. Household and individual resilience to shocks experienced in generalised epidemics can be supported through broader systems approaches within and beyond the health sector that help people to manage the interacting socioeconomic and health challenges of HIV. Examples include explicit interventions to strengthen social networks, increase spending on public services and community safety nets, introduce law reform and enforcement, invest in training and support for family carers, and increase access to education and employment opportunities.

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

HIV, TB, and national responses

HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Abdool Karim S S, Churchyard GJ, Abdool Karim QA, Lawn SD. Lancet 2009; 374: 921-33.

One of the greatest challenges facing post-apartheid South Africa is the control of the concomitant HIV and tuberculosis epidemics. HIV continues to spread relentlessly, and tuberculosis has been declared a national emergency. In 2007, South Africa, with 0.7% of the world's population, had 17% of the global burden of HIV infection, and one of the world's worst tuberculosis epidemics, compounded by rising drug resistance and HIV co-infection. Until recently, the South African Government's response to these diseases has been marked by denial, lack of political will, and poor implementation of policies and programmes. Nonetheless, there have been notable achievements in disease management, including substantial improvements in access to condoms, expansion of tuberculosis control efforts, and scale-up of free antiretroviral therapy. Care for acutely ill AIDS patients and long-term provision of antiretroviral therapy are two issues that dominate medical practice and the health-care system. Decisive action is needed to implement evidence-based priorities for the control of the HIV and tuberculosis epidemics. By use of the framework of the Strategic Plans for South Africa for tuberculosis and HIV, Abdool Karim and colleagues provide prioritised four-step approaches for tuberculosis control, HIV prevention, and HIV treatment. Strong leadership, political will, social mobilisation, adequate human and financial resources, and sustainable development of health-care services are needed for successful implementation of these approaches.

For full text access click here: 1

Editors’ note: This paper is a ‘must read’ for anyone wishing to understand the historical response to the intertwined HIV and tuberculosis (TB) epidemics in South Africa against a political backdrop. From a concentrated subtype B epidemic among men who have sex with men and patients with haemophilia in the early 1980s, the South African HIV epidemic evolved into a predominantly heterosexual clade C epidemic as mini-epidemics coalesced into a country-wide generalised epidemic, the worst in the world. Tuberculosis, which was introduced in the 17 th century from Europe and gained a firm toehold in the 19 th century in South Africa’s mining industry, is the most common notified natural cause of death in South Africa, with multidrug resistant (MDR) TB and extensively drug-resistant (XDR) TB now major causes for concern. This paper includes a scorecard that rates the government’s response in comparison with 5 neighbouring countries, Brazil, and India. It then lays out the challenges clearly, highlighting achievements to build upon, and sets out the priority action steps to achieve HIV and tuberculosis control. Failure is clearly not an option.

No votes yet
  • Share this!
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Men who have sex with men

Men who have sex with men and HIV/AIDS in sub-Saharan Africa. Smith AD, Tapsoba P, Peshu N, Sanders EJ, Jaffe H. Lancet. 2009;374: 416-422.

Globally, men who have sex with men continue to bear a high burden of HIV infection. In sub-Saharan Africa, same-sex behaviours have been largely neglected by HIV research up to now. The results from recent studies, however, indicate the widespread existence of groups of men who have sex with men across Africa, and high rates of HIV infection, HIV risk behaviour, and evidence of behavioural links between men who have sex with men and heterosexual networks have been reported. Yet most African men who have sex with men have no safe access to relevant HIV information and services, and many African states have not begun to recognise or address the needs of these men in the context of national HIV prevention and control programmes. The HIV community now has considerable challenges in clarifying and addressing the needs of men who have sex with men in sub-Saharan Africa; homosexuality is illegal in most countries, and political and social hostility are endemic. An effective response to HIV requires improved strategic information about all risk groups, including men who have sex with men. The belated response to men who have sex with men with HIV infection needs rapid and sustained national and international commitment to the development of appropriate interventions and action to reduce structural and social barriers to make these accessible.

For full text access click here: 1

 Editors’ note: Major barriers exist in access to effective HIV prevention, treatment, and care and support for men who have sex with men in sub-Saharan Africa. Not the least of these is the need for African political commitment to legal reforms and social protection for sexual minorities and those who work with them. It is not surprising that HIV subtypes in African men who have sex with men are similar to those occurring in the general population given that a high proportion of them report recent female sexual partners and many are married. What is surprising is how little is known about them. Only 17 of 52 African countries reported any information about risk knowledge and behaviour, HIV prevalence, and access to care among men who have sex with men in their 2008 reports of progress on the 2001 Declaration of Commitment. The silence must be broken to start to reverse the inaction that is so harmful to men who have sex with men, and to everyone else in Africa.

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Microbicides

 Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. O’Keefe BR, Vojdani F, Buffa V, Shattock RJ, Montefiori DC, Bakke J, Mirsalis J, d’Andrea AL, Hume SD, Bratcher B, Saucedo CJ, McMahon JB, Pogue GP, Palmer KE. Proc Natl Acad Sci U S A. 2009; 14;106:6099-104.

To prevent sexually transmitted HIV, the most desirable active ingredients of microbicides are antiretrovirals that directly target viral entry and avert infection at mucosal surfaces. However, most promising antiretroviral entry inhibitors are biologicals, which are costly to manufacture and deliver to resource-poor areas where effective microbicides are urgently needed. Here, O’Keefe and colleagues report a manufacturing breakthrough for griffithsin, one of the most potent HIV entry inhibitors. This red algal protein was produced in multigram quantities after extraction from Nicotiana benthamiana plants transduced with a tobacco mosaic virus vector expressing griffithsin (GRFT). Plant-produced GRFT (GRFT-P) was shown as active against HIV at picomolar concentrations, directly virucidal via binding to HIV envelope glycoproteins, and capable of blocking cell-to-cell HIV transmission. GRFT-P has broad-spectrum activity against HIV clades A, B, and C, with utility as a microbicide component for HIV prevention in established epidemics in sub-Saharan Africa, South Asia, China, and the industrialized West. Cognizant of the imperative that microbicides not induce epithelial damage or inflammatory responses, the authors also show that GRFT-P is nonirritating and noninflammatory in human cervical explants and in vivo in the rabbit vaginal irritation model. Moreover, GRFT-P is potently active in preventing infection of cervical explants by HIV-1 and has no mitogenic activity on cultured human lymphocytes.

For full text access click here: 1, 2

Editors’ note: This study reports an exciting new development on the microbicide front - using Nicotiana benthamiana, a close relative of Nicotiana tobaccum (tobacco), and a tobacco mosaic virus vector to produce large quantities of a red algal protein, griffithsin, that is both directly virucidal to HIV and blocks cell-to-cell HIV transmission. This HIV entry inhibitor is unlikely to be absorbed systemically when applied topically and the vector used to produce it here is already manufacturing proteins used in clinical trials. Critically, griffithsin does not induce any of the proinflammatory cytokines known to recruit HIV target cells and promote HIV replication. These findings provide support in favour of griffithsin now advancing to human trials.


Disruption of Tight Junctions by Cellulose Sulfate Facilitates HIV Infection: Model of Microbicide Safety. Mesquita, P. Cheshenko N, Wilson S, Mhatre M, Guzman E, Fakioglu E, Keller M, and Herold B. J Infect Dis. 2009;200:599-608.

The lack of biomarkers that are predictive of safety is a critical gap in the development of microbicides. The present experiments were designed to evaluate the predictive value of in vitro models of microbicide safety. Changes in the epithelial barrier were evaluated by measuring transepithelial electrical resistance (TER) after exposure of human epithelial cells to candidate microbicides in a dual-chamber system. The significance of observed changes was addressed by challenging cultures with HIV and measuring the ability of virus to cross the epithelium and infect target T cells cultured in the lower chamber. Exposure to nonoxynol-9 (N-9) or cellulose sulfate (CS), but not 9-[2-(phosphonomethoxy)propyl] adenine (also referred to as tenofovir) or PRO2000, resulted in a rapid and sustained reduction in TER and a marked increase in HIV infection of T cells cultured in the lower chamber. Moreover, cellulose sulfate triggered nuclear factor kB activation in peripheral blood mononuclear cells and increased HIV replication in chronically infected U1 cells. Epithelial barrier disruption and enhanced viral replication may have contributed to the increased risk of HIV acquisition observed in phase 3 trials of nonoxynol-9 and cellulose sulfate. Expansion of in vitro safety testing to include these models would provide a more stringent preclinical assessment of microbicide safety and may prove to be more predictive of clinical outcomes.

Abstract only : 1

Editors’ note: The microbicide field had faced setbacks in clinical trials, including the unanticipated finding of increased HIV acquisition in one of two recent phase III clinical trials of cellulose sulphate. To date, preclinical safety studies have included in vitro (outside the human body) measurements of cell viability and effects on lactobacilli, rabbit vaginal irritation, and a few macaque studies, while phase I safety studies in humans have looked for signs of irritation, assessed colposcopic abnormalities, measured inflammatory cytokines, or cultured specific bacteria. This innovative study assessed changes in electrical resistance and effects on junctional proteins in the vaginal epithelium when each of four microbicides was applied. The authors found that polarized cells provide a relatively impervious barrier to HIV migration through the epithelium. It is encouraging that neither PMPA (tenofovir) nor PRO 2000 0.5% disrupted epithelial tight junctions or activated inflammatory pathways. Both of these candidates are currently in trials: CAPRISA 004 and MDP 301, respectively. The results of these trials will help better determine the place of this methodology in the safety evaluation of future microbicide candidates but based on this report it does warrant serious consideration.

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

PMTCT health care delivery

Health workers’ views on quality of prevention of mother-to-child transmission and postnatal care for HIV-infected women and their children. Nguyen TA, Oosterhoff P, Pham YN, Hardon A, Wright P. Hum Resour Health. 2009;13;7:39.

Prevention of mother-to-child transmission has been considered as not a simple intervention but a comprehensive set of interventions requiring capable health workers. Viet Nam’s extensive health care system reaches the village level, but still HIV-infected mothers and children have received inadequate health care services for prevention of mother-to-child transmission. Nguyen and colleagues report here the health workers’ perceptions on factors that lead to their failure to give good quality prevention of mother-to-child transmission services. Semistructured interviews with 53 health workers and unstructured observations in nine health facilities in Hanoi were conducted. Selection of respondents was based on their function, position and experience in the development or implementation of prevention of mother-to-child transmission policies/programmes. Factors that lead to health workers’ failure to give good quality services for prevention of mother-to-child transmission include their own fear of HIV infection; lack of knowledge on HIV and counselling skills; or high workloads and lack of staff; unavailability of HIV testing at commune level; shortage of antiretroviral drugs; and lack of operational guidelines. A negative attitude during counselling and provision of care, treating in a separate area, and avoidance of providing service at all were seen by health workers as the result of fear of being infected, as well as distrust towards almost all HIV-infected patients because of the prevailing association with antisocial behaviours. Additionally, the fragmentation of the health care system into specialized vertical pillars, including a vertical programme for HIV, is a major obstacle to providing a continuum of care. Many hospital staff were not able to provide good care or were even unwilling to provide appropriate care for HIV-positive pregnant women The study suggests that the quality of prevention of mother-to-child transmission service could be enhanced by improving communication and other skills of health workers, providing them with greater support and enhancing their motivation. Reduction of workload would also be important. Development of a practical strategy is needed to strengthen and adapt the referral system to meet the needs of patients.

For full text access click here: 1

Editors’ note : This study was undertaken to find out the opinions of health care workers, who are subjected to many accusations about gaps and weaknesses in their performance, in Hanoi’s programme to prevent mother-to-child HIV transmission. The fragmentation of the health system, their own stigma from colleagues and family because of their exposure to HIV-infected patients, and their personal fear of HIV exposure in the absence of protective clothing and post-exposure kits all combine to reduce their motivation. They identified specific problems in their training and skills updating, a heavy workload, and a lack of equipment and materials. Remedying these will take varying lengths of time but seeking pragmatic solutions in the short term to produce tangible results could improve both the quality of patient care and the job satisfaction of health care personnel looking after them.


Early assessment of the implementation of a national programme for the prevention of mother-to-child transmission of HIV in Cameroon and the effects of staff training: a survey in 70 rural health care facilities. Labhardt ND, Manga E, Ndam M, Balo JR, Bischoff A, Stoll B. Trop Med Int Health 2009; 14: 288-93.

Labhardt and colleagues set out to assess the availability of equipment and the staff’s knowledge to prevent mother-to-child Transmission (PMTCT) in rural healthcare facilities recently covered by the national PMTCT programme in Cameroon. In eight districts inventories of antiviral drugs and HIV test kits were made on site, using a standardised check-list. Knowledge of HIV and PMTCT was evaluated with a multiple-choice questionnaire based on typical clinical PMTCT cases. Staff participated subsequently in a 2-day training on HIV and the Cameroon PMTCT guidelines. Immediately after training and after 7 months, retention of knowledge was tested with the same questions but in different order and layout. Sixty two peripheral nurse-led clinics and the eight district hospitals were assessed. Whereas all district hospitals presented complete equipment, only six of the peripheral clinics (10%) were equipped with both complete testing materials and a full set of drugs to provide PMTCT. Thirty six peripheral facilities (58%) possessed full equipment for HIV-testing and 8 (13%) stocked all PMTCT drugs. Of 137 nurses, 102 (74%) agreed to the two knowledge tests. Fewer than 66% knew that HIV-diagnosis requires positive results in two different types of rapid tests and only 19% chose the right recommendation on infant-feeding for HIV-positive mothers. Correct answers on drug regimens in different PMTCT settings varied from 25% to 56%. All percentages of correct answers improved greatly with training (P < 0.001) and retention remained high 7 months after training (P < 0.001). Programmes to prevent mother-to-child transmission in settings such as rural Cameroon need to be adapted to the special needs of peripheral nurse-led clinics. Appropriate short training may considerably improve nurses’ competence in PMTCT. Other important components are regular supervision and measures to guarantee supply of equipment in rural areas.

For abstract click here : 1

Editors’ note: Cameroon has set an ambitious objective of increasing the proportion of pregnant women who have access to HIV counselling and testing services from 10% to 50% by 2010. This study, conducted four to eight months after HIV test kits and antiretroviral drugs were distributed to health districts, found inadequate supplies of materials and low levels of staff awareness and knowledge of proper procedures. A two-day training programme including case-based interactive discussions led to sustained improvement in assessment scores. Guaranteeing the flow of equipment to peripheral clinics and maintaining health care worker competence through training and supportive supervision, will be key if Cameroon is to meet its 2010 objective.

 

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Gender

Role of widows in the heterosexual transmission of HIV in Manicaland, Zimbabwe, 1998-2003. Lopman BA, Nyamukapa C, Hallett TB, Mushati P, Spark-du Preez N, Kurwa F, Wambe M, Gregson S. Sex Transm Infect. 2009 85 Suppl 1:i41-8.

AIDS is the main driver of young widowhood in southern Africa. The demographic characteristics of widows, their reported risk behaviours, and the prevalence of HIV were examined by analysing a longitudinal population-based cohort of men and women aged 15-54 years in Manicaland, eastern Zimbabwe. The results from statistical analyses were used to construct a mathematical simulation model with the aim of estimating the contribution of widow behaviour to heterosexual HIV transmission. 413 (11.4%) sexually experienced women and 31 (1.2%) sexually experienced men were reported to be widowed at the time of follow-up. The prevalence of HIV was exceptionally high among both widows (61%) and widowers (male widows) (54%). Widows were more likely to have high rates of partner change and engage in a pattern of transactional sex than married women. Widowers took partners who were a median of 10 years younger than themselves. Mathematical model simulations of different scenarios of sexual behaviour of widows suggested that the sexual activity of widow(er)s may underlie 8-17% of new HIV infections over a 20-year period. This combined statistical analysis and model simulation suggest that widowhood plays an important role in the transmission of HIV in this rural Zimbabwean population. High-risk partnerships may be formed when widowed men and women reconnect to the sexual network.

For full text access click here: 1, 2

Editors’ note : The practice of widows marrying the brother of their deceased spouse, known as the ‘levirate’, appears to have declined in Zimbabwe, along with traditional practices discouraging widows from taking another partner for one year after the death of their spouse. Widows’ rights to inheritance are better protected, although less so for those married under customary law. Nevertheless, this modelling study in a rural area suggests that widows and widowers in this high prevalence setting are more likely to enter into high risk partnerships when they reconnect to the sexual network. Many of them likely need support and knowledge to make safe sexual choices after the death of a spouse. Widows in particular need legal advice and increased financial independence through employment opportunities to reduce their need for economic support from a new partner.

  

No votes yet
  • Share this!
No comment Add a comment
The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.